drugset / Trial / NCT04176133
Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination
RandomizedParallel-groupDouble-blindPrevention
Summary
Researchers are evaluating the safety and effectiveness of a single administration of entolimod when administered at the same time as the influenza vaccine (flu vaccine).
Timeline
- Start
- 2019-10-30
- Primary completion
- 2022-03-30
- Completion
- 2022-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entolimod | Unknown | 1 ug | Intramuscular |
| Subject | Entolimod | Unknown | 3 ug | Intramuscular |
| Subject | Entolimod | Unknown | 10 ug | Intramuscular |
| Background | Influenza Virus Vaccine | Vaccine | — | Intramuscular |
Indications
No indication recorded.